TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 97 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2015. The put-call ratio across all filers is 0.54 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,639 | -26.1% | 2,271 | -25.7% | 0.00% | – |
| Q2 2023 | $115,914 | +2797.8% | 3,056 | +2489.8% | 0.00% | – |
| Q3 2022 | $4,000 | -94.3% | 118 | -93.9% | 0.00% | – |
| Q2 2022 | $70,000 | -30.0% | 1,925 | -16.7% | 0.00% | – |
| Q1 2022 | $100,000 | -48.7% | 2,312 | -40.7% | 0.00% | – |
| Q4 2021 | $195,000 | -38.9% | 3,902 | -22.3% | 0.00% | – |
| Q3 2021 | $319,000 | -1.5% | 5,019 | +11.6% | 0.00% | – |
| Q2 2021 | $324,000 | -17.8% | 4,497 | -16.0% | 0.00% | – |
| Q1 2021 | $394,000 | +5.6% | 5,355 | +5.4% | 0.00% | – |
| Q4 2020 | $373,000 | +26.9% | 5,083 | -5.3% | 0.00% | – |
| Q3 2020 | $294,000 | +216.1% | 5,366 | +286.9% | 0.00% | – |
| Q2 2020 | $93,000 | -5.1% | 1,387 | -12.8% | 0.00% | – |
| Q1 2020 | $98,000 | -50.3% | 1,590 | -29.0% | 0.00% | – |
| Q4 2019 | $197,000 | +347.7% | 2,240 | +283.6% | 0.00% | – |
| Q3 2019 | $44,000 | -10.2% | 584 | +2.5% | 0.00% | – |
| Q2 2019 | $49,000 | -74.5% | 570 | -68.0% | 0.00% | – |
| Q1 2019 | $192,000 | +291.8% | 1,782 | +209.9% | 0.00% | – |
| Q4 2018 | $49,000 | -22.2% | 575 | -10.3% | 0.00% | – |
| Q3 2018 | $63,000 | -13.7% | 641 | +1.6% | 0.00% | – |
| Q2 2018 | $73,000 | +17.7% | 631 | +0.5% | 0.00% | – |
| Q1 2018 | $62,000 | -1.6% | 628 | +4.8% | 0.00% | – |
| Q4 2017 | $63,000 | -67.9% | 599 | -65.4% | 0.00% | – |
| Q3 2017 | $196,000 | +3.7% | 1,733 | +2.8% | 0.00% | – |
| Q2 2017 | $189,000 | +7.4% | 1,685 | +11.2% | 0.00% | – |
| Q1 2017 | $176,000 | -15.8% | 1,515 | -23.6% | 0.00% | – |
| Q4 2016 | $209,000 | +11.8% | 1,983 | +17.3% | 0.00% | – |
| Q3 2016 | $187,000 | -31.8% | 1,691 | -10.1% | 0.00% | – |
| Q2 2016 | $274,000 | -31.3% | 1,880 | -32.4% | 0.00% | – |
| Q1 2016 | $399,000 | -46.5% | 2,781 | -42.4% | 0.00% | – |
| Q4 2015 | $746,000 | +2.1% | 4,826 | -5.6% | 0.00% | – |
| Q3 2015 | $731,000 | -43.6% | 5,114 | -43.3% | 0.00% | – |
| Q2 2015 | $1,297,000 | -45.7% | 9,021 | -46.7% | 0.00% | – |
| Q1 2015 | $2,388,000 | +410.3% | 16,928 | +436.0% | 0.00% | – |
| Q4 2014 | $468,000 | +8.1% | 3,158 | +12.3% | 0.00% | – |
| Q3 2014 | $433,000 | +2992.9% | 2,812 | +2712.0% | 0.00% | – |
| Q2 2014 | $14,000 | -80.3% | 100 | -84.4% | 0.00% | – |
| Q1 2014 | $71,000 | -44.5% | 642 | -50.4% | 0.00% | – |
| Q4 2013 | $128,000 | +77.8% | 1,295 | +36.3% | 0.00% | – |
| Q3 2013 | $72,000 | +94.6% | 950 | +45.7% | 0.00% | – |
| Q2 2013 | $37,000 | – | 652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |